0 results for 'McCarter & English'
Lawyer-Lobbyist Receipts Continue to Outpace Overall Expenditures on State Lobbying
"My impression, overall, is that the utilization of law firms to take on government affairs projects and clients is increasing, which is really positive," David Pascrell, chair of Gibbons' government and regulatory affairs group, said.What's Ahead for the NCAA Following Preliminary Injunction Enjoining 'NIL-Recruitment Ban?'
"Generally, that means the court has pretty much made up its mind. Once you actually get past these preliminary issues, the court is saying, NCAA, you are going to lose," said Mit Winter, an attorney with Kennyhertz Perry in Kansas City, said.Marijuana in Highland Park: Lawyers Have Doubts About New Suit
"I think that upholding the supremacy of marijuana scheduling under the Controlled Substances Act is a weak argument," attorney Ryan Magee said. "And it gets weaker by the day."View more book results for the query "McCarter & English"
Case to Proceed Against McCarter & English
Both parties agreed that legal malpractice has a three-year statute of limitations, while breach-of-contract claims have a six-year statute of limitations.Fired Associate Says It's Not Easy Being a Conservative in Big Law
"If the legal community's going to cancel out diverse perspectives, that's not the right way. And that's what ... happened to me," former McCarter & English associate William D. Brown Jr. said.FTX Investors Claim Sullivan & Cromwell 'Aided' and Encouraged Fraud
S&C has generated $180 million "or 10% of the total revenue the 900-lawyer firm publicly stated it collected in all of 2022," according to a new lawsuit by FTX investors.McCarter & English Punitive Damages Question to Be Argued Before State High Court
State and federal trial courts have split on whether punitive damages are available for contract claims outside of the insurance context, according to a recent ruling from U.S. District Judge Michael Shea of the District of Connecticut.Judge Rejects Class Action Claim Filed Against Novo Nordisk, Eli Lilly and Sanofi-Aventis
"Plaintiffs have not sufficiently shown they failed to receive the benefit of the bargain as they have not alleged that they had 'a reasonable belief about the product induced by a misrepresentation'—and in fact they have asserted the opposite, that their ascertainable loss theory is not based on misrepresentation—or that they were misled into buying insulin that was worth less than was promised," Judge Brian R. Martinotti said.Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
Yearly Roundup: Strategic Insights for Law Firm Decision Making
Brought to you by CARET Legal
Download Now
Lex Machina Contracts: Commercial Litigation Report 2024
Brought to you by LexisNexis®
Download Now
White Collar Investigation Practice: Global Expertise in Complex Investigations
Brought to you by HaystackID
Download Now
Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review
Brought to you by NAVEX Global
Download Now